SIC
LH icon

SFE Investment Counsel’s Labcorp LH Stock Holding History

SFE Investment Counsel’s Portfolio LH Stock Details LH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.78M Buy
32,924
+135
+0.4% +$36.6K 1.38% 20
2025
Q4 		$8.23M Buy
32,789
+1,350
+4% +$359K 1.26% 25
2025
Q3 		$9.02M Sell
31,439
-650
-2% -$174K 1.44% 23
2025
Q2 		$8.42M Buy
32,089
+405
+1% +$98.6K 1.48% 18
2025
Q1 		$7.37M Buy
31,684
+3,195
+11% +$775K 1.47% 22
2024
Q4 		$6.53M Sell
28,489
-290
-1% -$66.5K 1.39% 27
2024
Q3 		$6.43M Buy
28,779
+5,101
+22% +$1.12M 1.34% 23
2024
Q2 		$4.82M Buy
23,678
+15,231
+180% +$3.1M 1.07% 38
2024
Q1 		$1.85M Sell
8,447
-2,080
-20% -$458K 0.42% 68
2023
Q4 		$2.39M Buy
10,527
+240
+2% +$50.4K 0.62% 58
2023
Q3 		$2.07M Sell
10,287
-2,206
-18% -$465K 0.6% 58
2023
Q2 		$2.59M Sell
12,493
-217
-2% -$42.1K 0.73% 49
2023
Q1 		$2.47M Sell
12,710
-419
-3% -$86.2K 0.76% 48
2022
Q4 		$2.85M Sell
13,129
-1,955
-13% -$382K 0.89% 43
2022
Q3 		$2.65M Buy
15,084
+142
+1% +$29.1K 0.84% 46
2022
Q2 		$3.01M Sell
14,942
-85
-0.6% -$18.1K 0.9% 45
2022
Q1 		$3.4M Buy
15,027
+6,579
+78% +$1.55M 0.86% 42
2021
Q4 		$2.28M Sell
8,448
-135
-2% -$33.4K 0.59% 53
2021
Q3 		$2.08M Buy
8,583
+35
+0.4% +$8.82K 0.58% 54
2021
Q2 		$2.03M Sell
8,548
-251
-3% -$57.2K 0.56% 56
2021
Q1 		$1.93M Buy
8,799
+879
+11% +$176K 0.56% 56
2020
Q4 		$1.39M Sell
7,920
-25
-0.3% -$4.32K 0.44% 62
2020
Q3 		$1.28M Sell
7,945
-268
-3% -$42.5K 0.51% 56
2020
Q2 		$1.17M Sell
8,213
-216
-3% -$29.9K 0.52% 55
2020
Q1 		$915K Buy
8,429
+140
+2% +$20.2K 0.5% 59
2019
Q4 		$1.21M Sell
8,289
-1,071
-11% -$155K 0.49% 61
2019
Q3 		$1.35M Sell
9,360
-104
-1% -$15.2K 0.57% 54
2019
Q2 		$1.41M Buy
9,464
+68
+0.7% +$9.49K 0.6% 51
2019
Q1 		$1.24M Sell
9,396
-1,681
-15% -$207K 0.56% 55
2018
Q4 		$1.2M Sell
11,077
-7,207
-39% -$965K 0.62% 48
2018
Q3 		$2.73M Buy
18,284
+5,589
+44% +$850K 1.05% 31
2018
Q2 		$1.96M Buy
12,695
+1,891
+18% +$285K 0.81% 37
2018
Q1 		$1.5M Sell
10,804
-2,781
-20% -$409K 0.78% 38
2017
Q4 		$1.86M Buy
13,585
+503
+4% +$66.5K 0.75% 42
2017
Q3 		$1.7M Sell
13,082
-838
-6% -$112K 0.71% 45
2017
Q2 		$1.84M Buy
13,920
+3,964
+40% +$485K 0.75% 45
2017
Q1 		$1.23M Buy
9,956
+6,452
+184% +$764K 0.45% 63
2016
Q4 		$400K Buy
+3,504
New +$389K 0.15% 90

Other funds holding LH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

SFE Investment Counsel's LH Position: Q1 2026 in Review

SFE Investment Counsel increased its Labcorp (LH) stake by 0.41% in Q1 2026, buying an estimated $36.6K and bringing the position to 32,924 shares worth $8.78M. The position accounts for 1.38% of the portfolio, ranked #20.

SFE Investment Counsel first reported a position in LH in Q4 2016 and has held it in 38 quarters since. The position peaked at $9.02M in Q3 2025. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.

  • SFE Investment Counsel held 32,924 shares of Labcorp worth $8.78M as of Q1 2026.
  • SFE Investment Counsel bought 135 Labcorp shares in Q1 2026, an estimated $36.6K.
  • Labcorp made up 1.38% of SFE Investment Counsel's portfolio in Q1 2026, its #20 holding.
  • SFE Investment Counsel first reported a position in Labcorp in Q4 2016 and has held it in 38 quarters since.
  • SFE Investment Counsel's Labcorp position peaked at $9.02M in Q3 2025.
  • 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on SFE Investment Counsel's 13F filing for Q1 2026, filed 1 May 2026.